Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Skin issues can indicate immune system problems.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Stress can cause hair loss by affecting nerve-related hair growth, and noradrenaline might help prevent this.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Iron deficiency might contribute to hair loss in women.

Histone modification is key in treating chronic inflammatory skin diseases.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

New treatments focusing on immune pathways show promise for stubborn hair loss.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Fibroblasts are important in healing diabetic wounds, but high sugar levels can harm their function and slow down the healing process.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.